- Report
- January 2026
- 150 Pages
Japan
From €4278EUR$4,850USD£3,709GBP
- Report
- November 2024
- 150 Pages
Global
From €4278EUR$4,850USD£3,709GBP
From €4278EUR$4,850USD£3,709GBP
- Report
- June 2025
- 77 Pages
Japan
From €2161EUR$2,450USD£1,874GBP
- Report
- June 2020
- 464 Pages
Global
From €4322EUR$4,900USD£3,747GBP
- Report
- November 2021
- 545 Pages
Global
From €3528EUR$4,000USD£3,059GBP
High Throughput Sequencing (HTS) is a biotechnology technique used to rapidly sequence large amounts of DNA or RNA. It is used to identify genetic variations, detect mutations, and analyze gene expression. HTS is used in a variety of applications, including drug discovery, diagnostics, and personalized medicine. It is also used in research to study the genetic basis of diseases, to identify biomarkers, and to understand the evolution of species.
HTS has revolutionized the biotechnology industry, allowing researchers to quickly and accurately sequence large amounts of genetic material. This has enabled the development of new treatments and diagnostics, as well as the identification of new biomarkers.
Companies in the HTS market include Illumina, Thermo Fisher Scientific, BGI, Pacific Biosciences, Oxford Nanopore Technologies, and 10X Genomics. Show Less Read more